On eve of Covid vaccine trial, Moderna touts another $472M federal investment

Moderna Therapeutics said Sunday that BARDA is injecting another $472 million in investment into the company to support its late-stage trial — set to begin Monday — of a potential vaccine for the Covid-19 coronavirus.